#Fluorescent In Situ Hybridization (FISH) Probe Market

[healthcarefuture]

DNA Probe-Based Diagnostics: Key Drivers, Market Trends, and Industry Insights

DNA Probe-based Diagnostics involve the use of DNA probes—single-stranded DNA sequences designed to detect the presence of complementary nucleic acid sequences. This method is highly specific, as it targets sequences unique to pathogens or genes of interest, enabling accurate identification of diseases at a molecular level. DNA probes are invaluable in diagnosing infections, genetic disorders, and cancers. In recent years, DNA Probe-based Diagnostics have advanced significantly, enabling quicker, more sensitive, and cost-effective tests compared to traditional diagnostic approaches. The probes often detect diseases earlier than conventional methods, which allows for timely interventions and treatment.

In 2022, the market for DNA probe-based diagnostics was projected to be worth 2.81 billion US dollars. By 2032, the DNA probe-based diagnostics market is projected to have grown from 3.09 billion USD in 2023 to 7.4 billion USD. During the forecast period (2024-2032), the DNA Probe-based Diagnostics Market is anticipated to develop at a CAGR of around 10.17%.

DNA Probe-based Diagnostics Size and Share

The global DNA Probe-based Diagnostics market has experienced substantial growth, driven by advancements in biotechnology, an increase in research activities, and rising demand for personalized medicine. This market’s size continues to expand, supported by high adoption rates in hospitals, clinics, and research laboratories. As of recent estimates, the market is expected to grow at a consistent compound annual growth rate (CAGR) over the next few years. This growth is fueled by increasing government initiatives, rising investments in healthcare infrastructure, and growing awareness of the importance of early disease detection.

The market share of DNA Probe-based Diagnostics is significant in the molecular diagnostics sector, with applications across diverse fields including infectious disease diagnostics, oncology, genetic testing, and forensic sciences. North America currently holds a major share, driven by the advanced healthcare infrastructure, high investment in research and development, and a strong focus on precision medicine. However, Asia-Pacific is anticipated to see the fastest growth due to increasing healthcare expenditures, rising prevalence of chronic diseases, and a growing demand for advanced diagnostic technologies.

DNA Probe-based Diagnostics Analysis

DNA Probe-based Diagnostics utilize several analysis methods that contribute to their accuracy and reliability. Techniques such as fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), and nucleic acid amplification tests (NAATs) are commonly employed in DNA probe diagnostics. Each method has its unique advantages: FISH, for instance, allows for the visualization of DNA in chromosomes, making it particularly useful in genetic and cancer diagnostics. PCR amplifies DNA sequences to enhance detection sensitivity, while NAATs are known for their high precision in identifying pathogenic DNA in low-abundance samples.

The analysis of DNA Probe-based Diagnostics reveals trends that continue to shape the industry, including the growing shift towards digital and point-of-care diagnostics, which are particularly valuable in low-resource settings. The trend of miniaturization and automation in DNA probe diagnostics has further improved throughput, making these diagnostics faster and more accessible to a larger population.

DNA Probe-based Diagnostics Trends

Several notable trends are currently driving the growth and development of DNA Probe-based Diagnostics. The first is the increase in demand for personalized and precision medicine, where diagnostics are tailored to individual genetic profiles, providing targeted treatments. Second, there is an expansion in the use of DNA probes for infectious disease diagnostics, especially in the detection of viruses such as COVID-19, which highlighted the need for rapid, accurate diagnostics. Third, advancements in microfluidics and lab-on-chip technologies are making diagnostics more compact and accessible. Fourth, automation and digitalization are improving the accuracy and speed of diagnostic results, and fifth, next-generation sequencing (NGS) technologies are pushing the limits of what DNA probes can detect.

Reasons to Buy DNA Probe-based Diagnostics Reports

Comprehensive Market Insight: Reports provide an in-depth understanding of the DNA Probe-based Diagnostics market, covering all segments, growth factors, challenges, and opportunities.

Competitive Analysis: Detailed profiles of key market players, their strategies, and competitive positioning give buyers a clear view of the competitive landscape.

Trend Analysis: Reports analyze current and emerging trends in the diagnostics market, providing data-driven insights to make informed decisions.

Strategic Recommendations: Clear, actionable insights help stakeholders identify areas of growth and potential investment opportunities.

Recent Developments: Reports cover the latest advancements, regulatory updates, and innovations within the DNA probe diagnostics field.

Recent Developments

Recent developments in DNA Probe-based Diagnostics include the integration of artificial intelligence (AI) for faster data interpretation and the launch of more portable diagnostic devices. The shift toward at-home diagnostic kits has also gained momentum, with many new products entering the market that allow patients to conduct self-tests. Additionally, advancements in CRISPR technology are enhancing the accuracy and versatility of DNA probes, especially in gene editing applications.

Related reports:

burn care centers market

cardiac output monitoring device market

cementless total knee arthroplasty market

Top of Form

Bottom of Form

[farmacuticals]

Market Insights: Drivers and Future Scope of DNA Probe-based Diagnostics

DNA Probe-based Diagnostics involve the use of DNA probes—single-stranded DNA sequences designed to detect the presence of complementary nucleic acid sequences. This method is highly specific, as it targets sequences unique to pathogens or genes of interest, enabling accurate identification of diseases at a molecular level. DNA probes are invaluable in diagnosing infections, genetic disorders, and cancers. In recent years, DNA Probe-based Diagnostics have advanced significantly, enabling quicker, more sensitive, and cost-effective tests compared to traditional diagnostic approaches. The probes often detect diseases earlier than conventional methods, which allows for timely interventions and treatment.

In 2022, the market for DNA probe-based diagnostics was projected to be worth 2.81 billion US dollars. By 2032, the DNA probe-based diagnostics market is projected to have grown from 3.09 billion USD in 2023 to 7.4 billion USD. During the forecast period (2024-2032), the DNA Probe-based Diagnostics Market is anticipated to develop at a CAGR of around 10.17%.

DNA Probe-based Diagnostics Size and Share

The global DNA Probe-based Diagnostics market has experienced substantial growth, driven by advancements in biotechnology, an increase in research activities, and rising demand for personalized medicine. This market’s size continues to expand, supported by high adoption rates in hospitals, clinics, and research laboratories. As of recent estimates, the market is expected to grow at a consistent compound annual growth rate (CAGR) over the next few years. This growth is fueled by increasing government initiatives, rising investments in healthcare infrastructure, and growing awareness of the importance of early disease detection.

The market share of DNA Probe-based Diagnostics is significant in the molecular diagnostics sector, with applications across diverse fields including infectious disease diagnostics, oncology, genetic testing, and forensic sciences. North America currently holds a major share, driven by the advanced healthcare infrastructure, high investment in research and development, and a strong focus on precision medicine. However, Asia-Pacific is anticipated to see the fastest growth due to increasing healthcare expenditures, rising prevalence of chronic diseases, and a growing demand for advanced diagnostic technologies.

DNA Probe-based Diagnostics Analysis

DNA Probe-based Diagnostics utilize several analysis methods that contribute to their accuracy and reliability. Techniques such as fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), and nucleic acid amplification tests (NAATs) are commonly employed in DNA probe diagnostics. Each method has its unique advantages: FISH, for instance, allows for the visualization of DNA in chromosomes, making it particularly useful in genetic and cancer diagnostics. PCR amplifies DNA sequences to enhance detection sensitivity, while NAATs are known for their high precision in identifying pathogenic DNA in low-abundance samples.

The analysis of DNA Probe-based Diagnostics reveals trends that continue to shape the industry, including the growing shift towards digital and point-of-care diagnostics, which are particularly valuable in low-resource settings. The trend of miniaturization and automation in DNA probe diagnostics has further improved throughput, making these diagnostics faster and more accessible to a larger population.

DNA Probe-based Diagnostics Trends

Several notable trends are currently driving the growth and development of DNA Probe-based Diagnostics. The first is the increase in demand for personalized and precision medicine, where diagnostics are tailored to individual genetic profiles, providing targeted treatments. Second, there is an expansion in the use of DNA probes for infectious disease diagnostics, especially in the detection of viruses such as COVID-19, which highlighted the need for rapid, accurate diagnostics. Third, advancements in microfluidics and lab-on-chip technologies are making diagnostics more compact and accessible. Fourth, automation and digitalization are improving the accuracy and speed of diagnostic results, and fifth, next-generation sequencing (NGS) technologies are pushing the limits of what DNA probes can detect.

Reasons to Buy DNA Probe-based Diagnostics Reports

Comprehensive Market Insight: Reports provide an in-depth understanding of the DNA Probe-based Diagnostics market, covering all segments, growth factors, challenges, and opportunities.

Competitive Analysis: Detailed profiles of key market players, their strategies, and competitive positioning give buyers a clear view of the competitive landscape.

Trend Analysis: Reports analyze current and emerging trends in the diagnostics market, providing data-driven insights to make informed decisions.

Strategic Recommendations: Clear, actionable insights help stakeholders identify areas of growth and potential investment opportunities.

Recent Developments: Reports cover the latest advancements, regulatory updates, and innovations within the DNA probe diagnostics field.

Recent Developments

Recent developments in DNA Probe-based Diagnostics include the integration of artificial intelligence (AI) for faster data interpretation and the launch of more portable diagnostic devices. The shift toward at-home diagnostic kits has also gained momentum, with many new products entering the market that allow patients to conduct self-tests. Additionally, advancements in CRISPR technology are enhancing the accuracy and versatility of DNA probes, especially in gene editing applications.

Related reports:

burn care centers market

cardiac output monitoring device market

cementless total knee arthroplasty market

Top of Form

Bottom of Form

[globalgrowthinsights]

Curved Televisions Market Size, Share, Demand, Growth and Forecast 2024-2032

Curved Televisions Market provides in-depth analysis of the market state of Curved Televisions manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Curved Televisions in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Curved Televisions Market Report:

The report offers a comprehensive and broad perspective on the global Curved Televisions Market.

The market statistics represented in different Curved Televisions segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Curved Televisions are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Curved Televisions.

Major stakeholders, key companies Curved Televisions, investment feasibility and new market entrants study is offered.

Development scope of Curved Televisions in each market segment is covered in this report. The macro and micro-economic factors affecting the Curved Televisions Market

Advancement is elaborated in this report. The upstream and downstream components of Curved Televisions and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/curved-televisions-market-100561

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Plasma Fractionation MarketMarket Forecast

Global Serial EEPROM MarketMarket Size

Software Development Services MarketMarket Growth

Medium Molecular Weight Polyisobutylene (PIB) MarketMarket Analysis

Protein Purification MarketMarket Size

Global Motor For Robots MarketMarket Share

Global Premium Spirit MarketMarket Growth

Personal Cloud MarketMarket

Bird Detection System MarketMarket Share

Wireless Charging System for Electric Vehicles MarketMarket Growth Rate

LTE Base Station System MarketMarket Forecast

Global Virtual Commissioning MarketMarket Size

Automotive Seat Frame MarketMarket Growth

Gas Barbecues MarketMarket Analysis

Active Nutrition MarketMarket Size

Global Document Scanning Services MarketMarket Share

Global Interactive Projector MarketMarket Growth

Cloud Computing Stack Layers MarketMarket

Organic Fruits and Vegetables MarketMarket Share

Smart Meter MarketMarket Growth Rate

E-prescribing MarketMarket Forecast

Global 5-hydroxymethylfurfural (5-HMF) (CAS 67-47-0) MarketMarket Size

Acrolein Diethyl Acetal MarketMarket Growth

Inflatable Boats MarketMarket Analysis

Automotive Dual Variable Valve Timing MarketMarket Size

Global Electroplating Equipment MarketMarket Share

Global Construction Composite MarketMarket Growth

Fluorescent In Situ Hybridization Probe (Fish Probe) MarketMarket

Hard Luxury Goods MarketMarket Share

Fancy Yarn MarketMarket Growth Rate

Flame Detector MarketMarket Forecast

Global Epidural Anesthesia Sets MarketMarket Size

Automotive Hydroformed Parts MarketMarket Growth

Commercial Cooking Equipment MarketMarket Analysis

Vacuum Lamination Equipment MarketMarket Size

Global Autonomous Mobile Robot MarketMarket Share

Global Floor Cable Protectors MarketMarket Growth

Multi-Axial Simulation Table MarketMarket

GPS Bike Lock MarketMarket Share

[myblogscmi]

Molecular Cytogenetics Market Is Estimated To Witness High Growth Owing To Increasing Demand for Genetic Testing

The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023 and is expected to exhibit a CAGR of 24.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

Molecular cytogenetics is a branch of genetics that focuses on the study of chromosomes and their abnormalities at a molecular level. It combines cytogenetic techniques with molecular biology to investigate the structure and function of chromosomes, as well as the genetic abnormalities associated with various diseases. The market offers a wide range of products such as fluorescent in situ hybridization (FISH) probes, comparative genomic hybridization (CGH) arrays, and karyotyping reagents, which are extensively used in research laboratories and diagnostic centers for genetic testing.

B) Market Dynamics:

The Molecular Cytogenetics Market is driven by two key factors. Firstly, there is a growing demand for genetic testing, especially in the field of personalized medicine, where genetic information is utilized to tailor treatment plans for individual patients. Genetic tests help in identifying genetic abnormalities that may cause diseases, enabling healthcare practitioners to make informed decisions regarding patient care. Moreover, advancements in technologies such as FISH and CGH arrays have made genetic testing more efficient and accurate, further contributing to market growth.

Secondly, there is a rising incidence of genetic disorders worldwide. According to the World Health Organization (WHO), birth defects are the leading cause of infant mortality and contribute significantly to childhood morbidity and disability. In addition, genetic disorders can also lead to adult-onset diseases such as cancer and neurodegenerative disorders. With an increasing awareness of the importance of early diagnosis, genetic testing has become an integral part of healthcare systems worldwide, driving the demand for molecular cytogenetics products.

C) Market Key Trends:

One key trend in the Molecular Cytogenetics Market is the increasing adoption of non-invasive prenatal testing (NIPT). NIPT is a genetic screening test that can detect the risk of certain chromosomal abnormalities in the fetus, such as Down syndrome, without the need for invasive procedures such as amniocentesis. The test is based on analyzing cell-free fetal DNA present in the maternal blood. NIPT offers several advantages over traditional methods, including higher accuracy, lower risk of complications, and earlier detection. This trend is expected to boost the demand for molecular cytogenetics products in the coming years.

D) SWOT Analysis:

Strengths:

- Advanced technologies such as FISH and CGH arrays offer high sensitivity and specificity in genetic testing.

- Increasing adoption of genetic testing in personalized medicine.

Weaknesses:

- High cost associated with molecular cytogenetics tests and equipment.

- Lack of awareness and accessibility in developing regions.

Opportunities:

- Growing application of molecular cytogenetics in oncology for cancer diagnosis and prognosis.

- Emerging markets such as Asia-Pacific offer significant growth opportunities.

Threats:

- Stringent regulatory requirements for genetic testing.

- Ethical concerns related to prenatal genetic testing.

E) Key Takeaways:

Paragraph 1: The global molecular cytogenetics market is expected to witness high growth, exhibiting a CAGR of 24.5% over the forecast period, due to increasing demand for genetic testing and rising incidence of genetic disorders.

Paragraph 2: North America is expected to dominate the market, followed by Europe, due to the presence of key players and a well-established healthcare infrastructure. However, the Asia-Pacific region is projected to be the fastest-growing market, owing to a growing population, rising healthcare expenditure, and increasing awareness about genetic testing.

Paragraph 3: Key players operating in the global molecular cytogenetics market include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc., among others. These players focus on product innovation, collaborations, and acquisitions to sustain their market position and expand their product portfolios.

[excellreports-blog]

Global Fluorescent In Situ Hybridization (FISH) Probe Industry Trends, Status, Benefits, growth and productivity

Excell Reports include new market research report “Fluorescent In Situ Hybridization (FISH) Probe Market” to its huge collection of research reports at the global and regional level. This report presents the worldwide Fluorescent In Situ Hybridization (FISH) Probe market size (value, Capacity, production and consumption), splits the breakdown (data status 2015-2019 and forecast to 2025), by manufacturers, region, type and application. The global Fluorescent In Situ Hybridization (FISH) Probe market is expected to grow at a significant CAGR during the forecast period. A stringent emission regulation is anticipated to drive the growth prospects for the market for the coming years. Health-care industry is grabbing the attention of all since last few years. The number of growing diseases and increasing concern and awareness about health are the factors contributing to the growth of Fluorescent In Situ Hybridization (FISH) Probe industry and its allied industries. Increasing use of innovations, and technologies, as well as increasing investments in R&D, is furthering the market scope and revenue growth of the global market.

The Global Fluorescent In Situ Hybridization (FISH) Probe Market to reach USD xx Million by 2015. Global Fluorescent In Situ Hybridization (FISH) Probe Market valued approximately USD xx million in 2018 is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2019-2025.This report provides in depth study of “Global Fluorescent In Situ Hybridization (FISH) Probe Market” using SWOT analysis Strength, Weakness, Opportunities and Threat to the organization. The report also studies the global market status, competitive landscape, market share, market drivers, opportunities and challenges, growth rate, future trends, sales channels, distributors, PEST and Porter's Five Forces Analysis. The report also focuses on the consumption, production, sales price, and capacity analysis in different geographies. Any special requirements about this report, please let us know and we can provide custom report.

•Get Report Sample and Customization:  https://www.excellreports.com/request-for-sample/?id=1630

The global Fluorescent In Situ Hybridization (FISH) Probe Market report, studies the market size, trends, ad forecasts for the period 2015 to 2025. The market is categorized on the basis of product, type, application, and end-use. The study also focuses on key regions including North America (U.S., Canada, and Mexico), South America (Brazil, Argentina etc.), Europe (Germany, U.K., France, Italy, Russia, and Spain etc.), Asia Pacific, and Middle East & Africa (Saudi Arabia, South Africa etc.), Japan, China, India.

•  The Report Highlights: •

• Overview of the industry, including definitions, classification and segmentation on the basis of application, product, geography and competitive market share

• All-inclusive assessment of the market

• Industry validated and statistically-supported market data

• Facts and statistics

• Business outlook and developments

• Market forecasts for the projected time frame

• Qualitative analyses (including SWOT analysis), product profiles and commercial developments.

• Key participants, company profiles, market trends, and business strategies

• The report is designed to incorporate both qualitative and quantitative aspects of the industry.

Some Important Chapter Covered In Fluorescent In Situ Hybridization (FISH) Probe Market Research are :

• Global Fluorescent In Situ Hybridization (FISH) Probe Market Definition and Scope

• Research Methodology

• Executive Summary

• Global Fluorescent In Situ Hybridization (FISH) Probe Market Dynamics

• Global Fluorescent In Situ Hybridization (FISH) Probe Market Industry Analysis

• Global Fluorescent In Situ Hybridization (FISH) Probe Market, By Product

• Global Fluorescent In Situ Hybridization (FISH) Probe Market by Technology

• Global Fluorescent In Situ Hybridization (FISH) Probe Market, By Application

• Global Fluorescent In Situ Hybridization (FISH) Probe Market by End User

• Global Fluorescent In Situ Hybridization (FISH) Probe Market, by Regional Analysis

• Company Market Share (Subject to Data Availability)

• Research Process

• Competitive Intelligence

• To view the complete table of contents and know more details please visit: •

https://www.excellreports.com/product/life-sciences/global-fluorescent-in-situ-hybridization-fish-probe-market-size-study-by-application-genetic-diseases-and-cancer-research-by-rna-type-mirna-mrna-and-others-by-end-use-clinical-research-a/

• Global Fluorescent In Situ Hybridization (FISH) Probe Market- By Type & Application (detailed segments and sub-segment) :

• Market Size Split By Application :

• Genetic diseases • Cancer research  o Lung  o Breast  o Other

• Market Size Split By RNA Type :

• miRNA        • mRNA        • Others

• Market Size Split By Application :

• Proteomics • Drug Development • Genomics • Others

• Market Size Split By End-User :

• Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Contract Research Organizations

• Companion Diagnostics

• Market Size Split By Regions:

• USA

• Europe

• Japan

• China

• India

• South East Asia

• Global Fluorescent In Situ Hybridization (FISH) Probe Market Participants :

• Genemed Biotechnologies, Inc.

• Oxford Gene Technologies

• Abnova Corporation

• Life Science Technologies

• AffymetrixPanomics

• PerkinElmer Inc And So On..

• Contact For Free Customization & Discount:

https://www.excellreports.com/inquire-for-discount/?id=1630

• About Us:

Excell reports is one of the leading distributors of Market Intelligence reports produced by premium publishers. Being a one stop solution for research requirements, our Market Intelligence reports help our clients to keep abreast of thousands of industries all-round the globe. A better understanding of the predicted market conditions, a clear picture of supply and source industries allows our clients to closely monitor competitor activities. Our large database of more than 50,000 quality driven reports from over 40+ leading publisher ensures that your market research requirements are sufficed.

• Contact Us:

Mr. Mark Johnson

Excell Reports

9701 Wilshire Boulevard 10th Floor

Beverly Hills, 

California 90212

Tel - +18448939235 

Email : sales@excellreports.com

Website : www.excellreports.com

[wemresearch]

Spatial Genomics and Transcriptomics Market Report 2022 to 2030 By Top Key Players, Types & Applications

The Spatial Genomics and Transcriptomics Market size was $163.8 million in 2020, and is expected to grow at a value of more than $470.55 million by 2030, registering a CAGR (Compound annual growth rate) of over 11% from 2022 to 2030.

Due to the rising potential of spatial genomic analysis as a cancer diagnosis tool and the arrival of the fourth generation of sequencing, the market for spatial genomics and transcriptomics will experience significant expansion. A desirable novel biomarker needed in many cancer types is genome placement. The use of spatial information as a diagnostic biomarker for many diseases was made possible by the discovery of spatial patterns in the genome for a number of medical problems. Biomarkers that enable more accurate classification between benign and malignant tumours are in increased demand. The need for spatial genomics analysis as a cancer detection tool is increasing as a result of this factor.

A research created by FutureWise Industry Research offers a thorough analysis of the market trends for spatial genomics and transcriptomics that will impact the expansion of the overall market. Additionally, it has comprehensive details on the profitability graph, SWOT analysis, market share, and regional expansion of this company. The study also provides information on the current status of important market participants in the examination of this industry's competitive landscape.

Spatial Genomics and Transcriptomics Market: Segmentation Analysis

Spatial Genomics and Transcriptomics Market by technology:

·         Spatial transcriptomics

Sequencing based methods

§  Laser capture microdissection

·         FFE tissue samples

·         Others

Transcriptome in-vivo analysis (TIVA)

In situ sequencing

Microtomy sequencing

·         IHC

·         Microscopy based RNA imaging techniques

Single molecule RNA fluorescence in-situ hybridization

Padlock probes/rolling circle amplification

Branched DNA probes

·         Spatial genomics

FISH

Microscopy-based live DNA imaging

Genome perturbation tools

Massively-parallel sequencing

Biochemical techniques

Others

The spatial transcriptomics section ruled the market with a revenue share of more than 80% in 2020 attributable to its high reception when contrasted with spatial genomic techniques for the transcriptomic study of single cells. The development of this section can likewise be ascribed to the accessibility of automated sequencing philosophies, for example, laser catch microdissection technique (LCM), to fulfil the growing need for nucleic acid sequencing of biological specimens or single cells.

Spatial Genomics and Transcriptomics Market by workflow:

Spatial imaging

Spatial analysis

Spatial sequencing.

Spatial Genomics and Transcriptomics Market by product type:

·         Instruments

By mode

§  Automated

§  Semi-automated

§  Manual

·         By type

Sequencing platform

IHC

Microscopy

Flow cytometry

Mass spectrometry

Others

·         Consumables

·         Software

Bioinformatics tools

Imaging tools

Storage and  management databases

Among these, Consumables Segment is expected to witness healthy growth during the forecast Period. The section is projected amplify substantially because of the rising occurrences of various chronic disease and cancer cases across the globe. Inferable from an increment in the rising rates, increasing R&D development are likely to push the market progression.

Spatial genomics and transcriptomics market by application: 

Translational research

Drug discovery & development

Others

Get Free Sample:- https://wemarketresearch.com/sample-request/spatial-genomics-and-transcriptomics-market/29/

Top Key Players:-

Akoya Biosciences, Inc.

BioSpyder Technologies Inc.

Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)

Dovetail Genomics, LLC

Fluidigm Corporation

Genomic Vision SA, Illumina, Inc.

Lunaphore Technologies SA

Nanostring Technologies, Inc.

Natera Inc.

PerkinElmer Inc. (Horizon Discovery Group Plc.)

Rarecyte, Inc.

Rebus Biosystems, LLC

Resolve Biosciences

S2 Genomic

Seven Bridges Genomics

Singular Genomics System, Inc.

Tecan Group Ltd. (Nugen Technologies, Inc.)

Ultivue, Inc.

Veranome Biosystems LLC

Vizgen Corporation

Interested in purchasing this Report? Click here:- https://wemarketresearch.com/purchase/spatial-genomics-and-transcriptomics-market/29/?license=single

Frequently Asked Questions (FAQ):

Q1. What is the total market value of spatial genomics and transcriptomic market report ?

Q2. What would be forecast period in the market report?

Q3. What is the market value of spatial genomics and transcriptomic market in 2021?

Q4. Which is base year calculated in the spatial genomics and transcriptomic market report?

Q5. Which are the top companies hold the market share in spatial genomics and transcriptomic market?

Q6. Which is the most influencing segment growing in the spatial genomics and transcriptomic market report?

Q7. What are the key trends in the spatial genomics and transcriptomic market report?

Q8. What are the market values / growth % of emerging countries?

Q9. What is spatial genomics and transcriptomic?

Q10. What are spatial genomics and transcriptomic used for?

About We Market Research

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone: +1(929)-450-2887

Email: sales@wemarketresearch.com 

Web: https://wemarketresearch.com/

[wemarketresearch]

Spatial Genomics and Transcriptomics Market Analysis 2022: Size, Share, Sales, Growth, Revenue, Type, Application & Forecast to 2030

The Spatial Genomics and Transcriptomics Market size was $163.8 million in 2020, and is expected to grow at a value of more than $470.55 million by 2030, registering a CAGR (Compound annual growth rate) of over 11% from 2022 to 2030.

The expanded acknowledgment of Spatial Genomics and Transcriptomics examination among private ventures and new companies is driving business sector extension, with applications in biomarker Identification. On the other hand, an absence of comprehensive methods in developing countries, as well as the significant expense of instruments, are impeding business sector extension.

The effect of the Covid-19 pandemic and resulting nation-wide lockdowns is seen in various sectors. The market expansion in various areas has been seriously hampered, especially in countries with high COVID-19 infection rate, like India, China, Brazil, the United States, and various European nations. While organizations like oil and petrol, flight, and mining are seeing a drop in income, the medical care, biotechnology, and drug enterprises are taking advantage of the situation to serve as many patients and medical services experts as possible. Albeit the COVID-19 pandemic will straightforwardly affect the Spatial Genomics and Transcriptomics market, its effect on the medical care markets will fuel the growth for Spatial Genomics and Transcriptomics market during and after the global epidemic.

Spatial Genomics and Transcriptomics Market: Key Trends

Expanding Adoption of Spatial Genomics and Transcriptomics in Drug Discovery and Development

Lately, the focal point of spatial genomics and transcriptomics has advanced from unadulterated review to drug disclosure and improvement. Genomics and transcriptomics are significant advancements for accelerating drug improvement and discovery. The worldwide burden of constant infections, for example, cancer and diabetes is persistently expanding, requiring the improvement of upgraded prescription research and development technologies. Different rivals in the spatial genomics and transcriptomics market are persistently creating and sending off new gear and strategies for drug discoveries and improvement. This is one of the essential drivers of market development.

Shortage of Trained Professionals

Information from genomics can be utilized for various purposes, including pharmacogenomics, diagnostics, and toxicogenomic. The investigation of enormous measures of information created in genomics research, on the other hand, is a serious trouble. It is crucial to have experts and professions who can accurately assess and interpret the results of genome sequencing information because of the complexities in the procedure and the necessity for inside and out understanding in the field of genomics. However, due to the dearth of qualified people, various end clients are experiencing issues handling genomic information.

Request A Sample Copy of Spatial Genomics and Transcriptomics Market: https://wemarketresearch.com/sample-request/spatial-genomics-and-transcriptomics-market/29/

Spatial Genomics and Transcriptomics Market: Segmentation Analysis

Based on technology, Spatial Genomics and Transcriptomics Market is bifurcated into Sequencing-based Methods (Laser Capture Microdissection (LCM), FFPE Tissue Samples, and others), Transcriptome In-vivo Analysis (TIVA) ( In Situ Sequencing and Microtomy Sequencing), IHC (Microscopy-based RNA Imaging Techniques, Single Molecule RNA Fluorescence In-situ Hybridization (smFISH), Padlock Probes/ Rolling Circle Amplification, Branched DNA Probes), and Spatial Genomics (FISH, Microscopy-based Live DNA Imaging, Genome Perturbation Tools, Massively-parallel Sequencing, Biochemical Techniques, and Others.

The spatial transcriptomics section ruled the market with a revenue share of more than 80% in 2020 attributable to its high reception when contrasted with spatial genomic techniques for the transcriptomic study of single cells. The development of this section can likewise be ascribed to the accessibility of automated sequencing philosophies, for example, laser catch microdissection technique (LCM), to fulfil the growing need for nucleic acid sequencing of biological specimens or single cells.

By workflow, the market is fragmented into spatial imaging, spatial analysis, and spatial sequencing. On the basis of product type, the industry is classified into-

• Instruments

o By mode (automated, semi-automated, and manual)

o By type (sequencing platforms, IHC, microscopy, flow cytometry, mass cytometry, and others)

• Consumables

• Software

o Bioinformatics tools

o Imaging tools

o Storage and management databases

Among these, Consumables Segment is expected to witness healthy growth during the forecast Period. The section is projected amplify substantially because of the rising occurrences of various chronic disease and cancer cases across the globe. Inferable from an increment in the rising rates, increasing R&D development are likely to push the market progression.

On the basis of application, the industry is classified into translational research, drug discovery & development, and others.

By end user, spatial genomics and transcriptomics market is divided into pharmaceutical manufacturer, diagnostic customers, academic & research institutes, and others. Among these, in 2019, the academic & research institutes section accounted for the largest share of the spatial genomics and transcriptomics market. Market development can to a great extent be credited to the increment in research intensity in this end-client section and the accessibility of sufficient grants and assets for research.

Purchase Global Spatial Genomics and Transcriptomics Market Research Report at Single User Access - $ 4750: https://wemarketresearch.com/purchase/spatial-genomics-and-transcriptomics-market/29/?license=single

Report Scope:

• Spatial Genomics and Transcriptomics Market Forecast Year: 2021-2030

• Spatial Genomics and Transcriptomics Market 2020: USD 1,487 Million

• Spatial Genomics and Transcriptomics Market 2030: USD 2,419 Million

• Spatial Genomics and Transcriptomics Market CAGR: 4.9%

• Key Regions and Countries: North America, Europe, Asia Pacific, LAMEA

• Key Segments: Product Type, Application, Material, Component, and End-User

About We Market Research

We Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. We Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

Contact Us:

We Market Research

Phone:

+1(929)-450-2887

Email

:

sales@wemarketresearch.com

[fusionmarketresearch]

Fluorescent In Situ Hybridization (FISH) Probe Market 2022: Global Industry Analysis and Opportunity and Forecast To 2029

Fluorescent In Situ Hybridization (FISH) Probe Market 2022: Global Industry Analysis and Opportunity and Forecast To 2029

Fluorescent In Situ Hybridization (FISH) Probe Market 2022-2028 A New Market Study, Titled “Fluorescent In Situ Hybridization (FISH) Probe Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch. Description This global study of the Fluorescent In Situ Hybridization (FISH) Probe Market offers an overview of the existing market trends, drivers,…

[globalaircraft]

Global Flourescent in Situ Hybridization (FISH) Probe Market Size and Challenges to 2026

Global Flourescent in Situ Hybridization (FISH) Probe Market will exhibit a CAGR of 6.6% for the forecast period of 2019-2026

Global Flourescent in Situ Hybridization (FISH) Probe Market Analysis and Insights:

Global Flourescent in situ hybridization probe market is expected to register a substantial CAGR of 6.6% in the forecast period of 2019-2026. This rise in the market can be attributed to the increase in use of FISH probes for diagnosis of infectious viruses, initiatives taken by the government and rise in awareness among people for benefits of FISH probe technique.

Fluorescent in situ hybridization (fish) would help in the identification of position of genes. It is used in clinic for diagnosing the chromosomal abnormalities including duplications, deletions and translocations etc. FISH has wide applications in research labs and clinics for monitoring the after effects of therapies, tracking of cells after transplantation etc. Many developments are taking place in FISH market including DNA probe-based diagnostics which assists in the determination of suspected diseases caused by any bacteria.

Global Flourescent in Situ Hybridization (FISH) Probe Market Scope and Market Size:

By Technology

FISH, Q FISH, Flow-FISH, CISH, DISH

By Type

DNA, RNA, mRNA, miRNA

By Application

Cancer Research, Lung, Breast, Bladder, Hematological, Gastric, Prostrate, Cervical

Global Flourescent in Situ Hybridization (FISH) Probe Market Country Level Analysis:

The countries covered in Flourescent in situ hybridization probe market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Get Sample Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-flourescent-in-situ-hybridization-fish-probe-market

Get full Report: https://www.databridgemarketresearch.com/reports/global-flourescent-in-situ-hybridization-fish-probe-market

Competitive Landscape & Global Flourescent in Situ Hybridization (FISH) Probe Market Share Analysis:

Flourescent in situ hybridization probe market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Flourescent in situ hybridization probe market.

Major Players:

Oxford Gene Technology

Agilent Technologies Inc

PerkinElmer Inc

Horizon Discovery Group plc

BioDot

Sysmex Singapore Pte. Ltd

Major TOC of the Report:

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insight

Chapter Six: COVID-19 Impact on Global Flourescent in situ hybridization probe Market

Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=global-flourescent-in-situ-hybridization-fish-probe-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[chitrakullkarni]

Fluorescent In Situ Hybridization (FISH) Probe Market PESTEL Analysis and Key Growth Opportunities

The global Fluorescent In Situ Hybridization (FISH) Probe Market is expected to display higher growth rate over the next seven years. Rapid surge in the fluorescent in situ hybridization probes market is credited to the rising demand for molecular diagnostic tools and increasing adoption of ISH technology. Growing prevalence of chronic diseases along with rising demand for rapid diagnostic techniques are anticipated to foster market growth over the forecast period.

Globally, the fluorescent in situ hybridization (FISH) probe industry is predicted to generate massive revenue over next seven years, providing numerous opportunities for market players to invest for research and development in the FISH probe market. The conventional methodologies such as clinical trials were influenced by factors such as the growing competition, rising prices of medicines and strict governmental laws to limit adverse effects on the environment. With advent of the In Situ hybridization devices, such factors are significantly diminished due to numerous advantages associated with fluorescent In Situ hybridization devices.

Benefits associated with adoption of fluorescent In Situ hybridization devices are superior performance, successful trials, reliability and short timeframes for execution of clinical trial, and cost-effectiveness. Rising prevalence of cancer-related diseases is expected to boost market demand fluorescent in situ hybridization probe industry over the upcoming years. In addition, increasing adoption of DNA probe-based diagnostics for identification of diseases that are caused by pathogen or bacteria is estimated to drive market growth.

Rise in the number of incidence related to genetic disorders, solid tumors, leukemia, autism, and other syndromes are predicted to stimulate market demand for FISH Probe over the forecast period. Fluorescent in situ hybridization probes offer an advanced analytical method to monitor gene aberration, including gene amplification and deletion. Fluorescent in situ hybridization probe (FISH Probe) is also responsible for gene copy number change, chromosome translocation, gene expression at RNA level, and bacterial detection.

Request free sample to get a complete analysis @ https://www.millioninsights.com/industry-reports/fluorescent-in-situ-hybridization-fish-probe-market/request-sample

The fluorescent in situ hybridization probe market is broadly categorized into three major segments based on the application type such as research and development labs, hospitals & clinics, and companion diagnostics. The hospitals & clinics segment is growing rapidly in the with substantial revenue generation in the last few years. Growing popularity of fluorescent in situ hybridization probes in the hospitals & clinics segment is attributed to the broad range of application involving detection of genetic disorders, cancer, and infectious diseases.

The FISH probe industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in gene therapy, surge in number of research & development activities in the region and existence of well-established healthcare infrastructure.

Asia-Pacific region is estimated to hold major share in the FISH probes market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with rising healthcare expenditure, increasing disposable income, favorable government initiatives to promote use of advanced technologies in healthcare sector, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the fluorescent in situ hybridization probes industry are Oxford Gene Technology IP Ltd., Life Science Technologies Ltd., PerkinElmer Inc., Abnova Co., Biosearch Technologies Inc., Genemed Biotechnologies, Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Inc., and Agilent Technologies Ltd.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/ 

[market-researchm]

Global In Situ Hybridization (ISH) Market Analysis, Share, Growth, Industry Trends, Overview And Forecast To 2025

Global In Situ Hybridization (ISH) Market is expected to reach USD 1.84 billion by 2025. In Situ Hybridization (ISH) is a type of hybridization a method that permits for specific localization of an exact segment of nucleic acid inside a histologic section. That means it involves the use of labeled RNA probes or labeled DNA probes to detect complementary DNA or RNA targets in cytologic preparations or tissue sections. Synthetic oligonucleotides (PNA, LNA), Double-stranded DNA (dsDNA) probes, RNA probes (riboprobes), and Single-stranded DNA (ssDNA) probes are the majorly used ISH probes.

It can be labeled using two major techniques like Non-radioactive labels and radioactive isotopes. A labeled RNA or DNA probe can be used to hybridize to a known target DNA or mRNA sequence within a sample. This labeled RNA or DNA probe can then be detected by using an antibody to detect the label on the probe. The In Situ Hybridization (ISH) industry is estimated to grow at a significant CAGR of 7.3% over the future period as the scope and its applications are rising enormously across the globe. In Situ Hybridization (ISH) Market is segmented based on product type, technology, probe type, application, end use, and region.

Services, instruments, software, and kits & probes are the product types that could be explored in In Situ Hybridization (ISH) in the forecast period. The instruments sector accounted for the largest market share of In Situ Hybridization (ISH) industry and is estimated to continue its dominance in the upcoming years. This may be because of high demand from research laboratories and diagnostic centers. Also, these instruments are easy to handle, cost-efficient, and portable these factors may lead the sector in coming years. However, kits & probes sector is estimated to grow at highest CAGR in the coming years.

Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market/request-sample

The enhanced technology used in In Situ Hybridization (ISH) is Chromogenic In Situ Hybridization (CISH) and Fluorescent In Situ Hybridization (FISH) that could be explored in the future period. RNA probe and DNA probe are the two main types of probes that could be explored in In Situ Hybridization (ISH) in the foremost period. The DNA probes sector is estimated to account largest revenue shares of In Situ Hybridization (ISH) in the coming years. Whereas, RNA sector is estimated to grow at highest CAGR in the coming years.

The market may be categorized based on applications like infectious diseases, cancer, developmental biology, cytogenetics, and others that could be explored in the future period. Cancer sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to grow at highest CAGR in the coming years. The reason could be growing occurrence of cancer and rising research in this sector. However, cytogenetics sector is estimated to grow at fastest pace in the coming years.

End users like academic institutes, research & diagnostic laboratories, contract research organizations (CROs), and others could be explored in In Situ Hybridization (ISH) Market in the forecast period. The research & diagnostic laboratories sector accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the coming years. This may be because of growing applications of molecular cytogenetics in diagnostics, rising use of enhanced technology in genomics and molecular cytology, and rising initiative in cell research. However, CROs segment is estimated to grow at fastest pace in the coming years.

Globally, North America accounted for the largest market share of In Situ Hybridization (ISH) and is estimated to lead the overall market in the upcoming years. The reason behind the growth of overall market could be government involvement for development of novel diagnostic tools, availability of research funds, and developed research centers. The United States is a major consumer of In Situ Hybridization (ISH) in this region.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, growing awareness regarding advantages of In Situ Hybridization (ISH) technology in diagnostics and government initiative in R&D investments in the field of molecular biology. The developing countries like India and China are the major consumers of In Situ Hybridization (ISH) industry in the region.

The key players of In Situ Hybridization (ISH) Market are Oxford Gene Technology, Thermo Fisher Scientific, Advanced Cell Diagnostics, Inc., Leica BiosystemsNussloch GmbH, NeoGenomics Laboratories, Inc., BIOVIEW, Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Access Full Research Report @ https://www.millioninsights.com/industry-reports/in-situ-hybridization-ish-market

[esglatestmarketnews]

Fluorescent In Situ Hybridization (FISH) Probe Market Statistical Forecast and Analysis Report till 2022

August 19, 2021: The global Fluorescent In Situ Hybridization (FISH) Probe Market is expected to display higher growth rate over the next seven years. Rapid surge in the fluorescent in situ hybridization probes market is credited to the rising demand for molecular diagnostic tools and increasing adoption of ISH technology. Growing prevalence of chronic diseases along with rising demand for rapid diagnostic techniques are anticipated to foster market growth over the forecast period.

Globally, the fluorescent in situ hybridization (FISH) probe industry is predicted to generate massive revenue over next seven years, providing numerous opportunities for market players to invest for research and development in the FISH probe market. The conventional methodologies such as clinical trials were influenced by factors such as the growing competition, rising prices of medicines and strict governmental laws to limit adverse effects on the environment. With advent of the In Situ hybridization devices, such factors are significantly diminished due to numerous advantages associated with fluorescent In Situ hybridization devices.

Benefits associated with adoption of fluorescent In Situ hybridization devices are superior performance, successful trials, reliability and short timeframes for execution of clinical trial, and cost-effectiveness. Rising prevalence of cancer-related diseases is expected to boost market demand fluorescent in situ hybridization probe industry over the upcoming years. In addition, increasing adoption of DNA probe-based diagnostics for identification of diseases that are caused by pathogen or bacteria is estimated to drive market growth.

Request a Free Sample Copy of this Report @ https://www.millioninsights.com/industry-reports/fluorescent-in-situ-hybridization-fish-probe-market/request-sample

Rise in the number of incidence related to genetic disorders, solid tumors, leukemia, autism, and other syndromes are predicted to stimulate market demand for FISH Probe over the forecast period. Fluorescent in situ hybridization probes offer an advanced analytical method to monitor gene aberration, including gene amplification and deletion. Fluorescent in situ hybridization probe (FISH Probe) is also responsible for gene copy number change, chromosome translocation, gene expression at RNA level, and bacterial detection.

The fluorescent in situ hybridization probe market is broadly categorized into three major segments based on the application type such as research and development labs, hospitals & clinics, and companion diagnostics. The hospitals & clinics segment is growing rapidly in the with substantial revenue generation in the last few years. Growing popularity of fluorescent in situ hybridization probes in the hospitals & clinics segment is attributed to the broad range of application involving detection of genetic disorders, cancer, and infectious diseases.

The FISH probe industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in gene therapy, surge in number of research & development activities in the region and existence of well-established healthcare infrastructure.

Asia-Pacific region is estimated to hold major share in the FISH probes market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with rising healthcare expenditure, increasing disposable income, favorable government initiatives to promote use of advanced technologies in healthcare sector, and significant investment by leading industry players considering potential growth opportunities in the region.

Browse Full Research Report @ https://www.millioninsights.com/industry-reports/fluorescent-in-situ-hybridization-fish-probe-market

The key players in the fluorescent in situ hybridization probes industry are Oxford Gene Technology IP Ltd., Life Science Technologies Ltd., PerkinElmer Inc., Abnova Co., Biosearch Technologies Inc., Genemed Biotechnologies, Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Inc., and Agilent Technologies Ltd.

Market Segment:

FISH Probe End-use Outlook (Revenue, USD Million, 2012 - 2022)

• Research

• Clinical

• Companion diagnostics

FISH Probe RNA Outlook (Revenue, USD Million, 2012 - 2022)

• mRNA

• miRNA

• Other

FISH Probe Application Outlook (Revenue, USD Million, 2012 - 2022)

• Cancer research

• Lung

• Breast

• Other

• Genetic diseases

• Genetic Diseases

• Other

FISH Probe Technology Outlook (Revenue, USD Million, 2012 - 2022)

• FISH

• Q FISH

• Flow-FISH

• Other

• CISH

• DISH

FISH Probe Market Regional Outlook (Revenue, USD Billion, 2012 - 2022)

• North America

• U.S.

• Canada

• Europe

• Germany

• UK

• Asia Pacific

• Japan

• China

• India

• Latin America

• Mexico

• Brazil

• MEA

• South Africa

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com